
STAT+: Lawmakers want U.S. biotech to outcompete China
Lawmakers leading the congressional BIOTech Caucus say Washington needs to act in the sector — and fast:

Lawmakers leading the congressional BIOTech Caucus say Washington needs to act in the sector — and fast:

Did the biotech company Erasca find a more potent, better-tolerated pan-RAS cancer drug than Revolution Medicines?

China is intensifying efforts to control the entire drug supply chain, putting the U.S. at risk of being cut off from future lifesaving treatments, the National Security Commission on Emerging Biotechnology warns in a new analysis out Thursday. Why it matters: Western drug giants have invested huge sums in Chinese biotechs to boost their product pipelines. But sharing capital and expertise could give Beijing more control over critical pharmaceutical technologies. Concerns…
Nature Biotechnology, Published online: 19 November 2026; doi:10.1038/s41587-026-03362-3 RhoAgent designs functional RNA molecules by constraining secondary structure, base interactions and functional motifs.

The FDA published its complete response letter to Summit Therapeutics explaining why it rejected the biotech's closely watched lung cancer drug:

A lag in foundational research and looming geopolitical risks will weigh on China’s bid to build a world-class biotechnology innovation ecosystem, even as the sector’s overseas momentum remains strong, according to JPMorgan. “In China, there is still some catching up to do in basic research, particularly in biological and pharmaceutical research,” said Yang Huang, head of China healthcare research at JPMorgan, during an interview on Wednesday. To meet the “ambitious goal”…

Hong Kong needs more “patient capital” and more talent capable of commercialising research and development to sustain the city’s biotechnology ecosystem, according to a senior executive at a local biotech start-up. Yicura BioMed, based in the Hong Kong Science Park, is heading towards an initial public offering (IPO) in the city as soon as practicable, CEO Xian Jin said in an interview. “Biotech start-up fundraising in Hong Kong is never an easy game to play,” Jin said…

4 Mins ReadAustralian biotech startup All G has self-determined its precision-fermented human lactoferrin as GRAS in the US, the first in an expanding pipeline of breast milk proteins. All G has been cleared to sell its recombinant human lactoferrin protein in the US. The Sydney-based firm has secured self-affirmed Generally Recognized as Safe (GRAS) status for its

Karnataka aims to become a global hub for frontier technologies such as AI, deeptech, and biotech, said CM DK Shivakumar at Bengaluru Tech Summit. Meanwhile, Maharashtra CM Fadnavis has shared his roadmap for a trillion-dollar, drought-free, deeptech Maharashtra by 2035.

Flagship is putting up 100 million pounds to start “AI-native platform companies" focused on human and planetary health in the U.K.:

Even as the larger AI industry faces turmoil, investors have given Isomorphic the two largest cash infusions in the biotech sector this year.

In this Q&A, Mike Bellin, a partner and U.S. IPO services leader at PricewaterhouseCoopers, discussed the slowdown in IPO momentum, how public investors are evaluating AI companies, biotech’s resurgence and why SPACs are attracting renewed interest. He also outlined what could set the stage for a stronger start to 2027.

Karnataka Chief Minister DK Shivakumar said the strong technology ecosystem in the State gives it the advantage to lead in areas such as AI, biotech, semiconductor and robotics.
Nature Biotechnology, Published online: 17 November 2026; doi:10.1038/s41587-026-03405-9 Author Correction: The global patent landscape of bispecific antibodies: technological innovations and therapeutic applications

Biotechnology research including growing human lung cells and managing blood flow in space awaited the Expedition 75 crew on Monday. Spacesuit checks, cargo packing, and Earth observations rounded out the busy schedule aboard the International Space Station at the beginning of the week.

Biotech is having a good year, though you wouldn't necessarily know it from how investors are treating positive clinical data.

Bengaluru Tech Summit 2026 aims to extend AI adoption beyond enterprise software into agriculture, biotechnology, gaming, industrial systems, and e-governance.

A new STAT-WireScreen index ranks China's most valuable publicly traded biotech companies. See which one topped the list.
Sofinnova Partners, which has backed the likes of successful drugmakers such as Abivax, Argenx and Verona Pharma, will use the cash to support a new group of later-stage biotechs.
Nature Biotechnology, Published online: 16 November 2026; doi:10.1038/s41587-026-03344-5 Adeno-associated virus vectors targeted to CD7 enable T and NK cell engineering in vivo.

The FDA has rejected ivonescimab, a treatment for a type of lung cancer developed by U.S. biotech Summit Therapeutics and the Chinese drugmaker Akeso.

4 Mins ReadIndian biotech firm Symbiotec Pharmalabs has signed a 10-year deal to serve as a contract manufacturer for a European company’s precision-fermented protein. Shoring up India’s biomanufacturing prowess, Symbiotec Pharmalabs has expanded its contract manufacturing services for a European innovator in alternative proteins. The biotech firm has signed a 10-year take-or-pay agreement with an unnamed European

Is biotechnology becoming the next space race? The Biotechnology Innovation Organization (BIO) appears to think so. This month, it urged Washington to adopt a comprehensive national biotechnology strategy, warning that China is rapidly gaining ground in an industry now viewed as critical to economic competitiveness and national security. The United States and China have spent

The Swiss biotech has two prospects it sees as having the potential to outcompete AstraZeneca and Amgen's blockbuster asthma treatment Tezspire.
Nature Biotechnology, Published online: 13 November 2026; doi:10.1038/s41587-026-03379-8 False discovery rate (FDR) control is central to omics research, yet the diverse procedures used rely on different assumptions. This Comment proposes a 2 × 2 matrix that helps sequencing-based and mass-spectrometry-based omics researchers choose the appropriate family of FDR procedures, or alternative methods that may be more rigorous, depending on data and study design.

5 Mins ReadCalifornian sweet protein pioneer Oobli has agreed to an acquisition by Amyris, a biotech firm specialising in precision fermentation, to expand the scale of its sugar reduction portfolio. US biomanufacturing company Amyris has announced it will acquire Oobli, a California-based producer of precision-fermented sweet proteins. The transaction amount is undisclosed. It combines the former’s strain

Alnylam is heavily dependent on its heart drug Amvuttra for growth — and sales have been slowing.
Nature Biotechnology, Published online: 12 November 2026; doi:10.1038/s41587-026-03378-9 An analysis of Investigational New Drug (IND) submissions to the US Food and Drug Administration (FDA) from 1995 to 2025 reveals a rapid growth in adeno-associated virus (AAV) development over three decades and highlights common reasons for regulatory holds that should be considered for successful product development.

Biscay (Bizkaia), in Spain’s Basque Country, is building on its industrial heritage to develop a startup ecosystem spanning biotechnology, advanced manufacturing, energy and emerging technologies. Wit...

The deal gives AstraZeneca a simpler way to make conjugate vaccines. Elsewhere, a psychedelic depression drug was submitted to the FDA and an autoimmune disease-focused biotech’s shares collapsed.